FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200716E00066
1. Date of relevant event: 15/07/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01877
4. Name of listed corporation: Shanghai Junshi Biosciences Co., Ltd. - H Shares 
5. Class of shares: A Shares 
6. Number of issued shares in class: 688,530,000
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) TANG
(Other names) Yi
10. Name of director (Chinese): 湯毅 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1701Miscellaneous
On listing of the corporation or a class of shares of the listed corporation
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 		 203,325,236         
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position203,325,23633.81
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position203,325,23629.53
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position7,774,500
2201Interest of corporation controlled by you
Long position195,550,736
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
深圳前海源本股权投资基金管理有限公司中国广东省深圳市前海深港合作区前湾一路鲤鱼门街1号前海深港合作管理局综合办公楼A栋201室 (中国)Tang Yi60.00N
Long position195,550,736
苏州本裕天源生物科技合伙企业(有限合伙)中国江苏省苏州工业园区唯正路8号 (中国)深圳前海源本股权投资基金管理有限公司86.28Y
Long position4,600,000
苏州本裕天源生物科技合伙企业(有限合伙)中国江苏省苏州工业园区唯正路8号 (中国)深圳前海源本股权投资基金管理有限公司86.28N
Long position190,950,736
苏州瑞源盛本生物医药管理合伙企业(有限合伙)中国江苏省苏州市吴江区松陵镇开发区云黎路北侧 (中国)深圳前海源本股权投资基金管理有限公司39.52Y
Long position43,584,000
苏州瑞源盛本生物医药管理合伙企业(有限合伙)中国江苏省苏州市吴江区松陵镇开发区云黎路北侧 (中国)深圳前海源本股权投资基金管理有限公司39.52N
Long position151,966,736
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: On 15 July 2020, the Company's 601,400,000 Domestic Shares were converted into A Shares and the Company newly issued 87,130,000 A Shares. As a result, the percentage level of Tang Yi's interest in the Company's A Shares has reduced.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded: 0
Date of filing this Form 3A: 16/07/2020
(dd/mm/yyyy)